TY - JOUR
T1 - Measuring treatment outcomes in comorbid insomnia and fibromyalgia
T2 - concordance of subjective and objective assessments
AU - Mundt, Jennifer Marie
AU - Crew, Earl C.
AU - Krietsch, Kendra
AU - Roth, Alicia J.
AU - Vatthauer, Karlyn
AU - Robinson, Michael E.
AU - Staud, Roland
AU - Berry, Richard B.
AU - Mccrae, Christina S.
N1 - Funding Information:
The authors thank and acknowledge the efforts of the study coordinator, Christine Towler; study therapists Ryan Anderson, Daniela Roditi, and Jacob Williams; the registered polysomnographic technologist, Susan Purdy; and the undergraduate research assistants in the UF Sleep Research Lab. This was not an industry supported study. This research was supported by a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR055160; Christina McCrae, PI; Michael Robinson, Co-PI). Dr. Staud has received research support from Pfizer. The other authors have indicated no financial conflicts of interest. Work was performed at the University of Florida, Gainesville, FL.
PY - 2016
Y1 - 2016
N2 - Study Objectives: In insomnia, actigraphy tends to underestimate wake time compared to diaries and PSG. When chronic pain co-occurs with insomnia, sleep may be more fragmented, including more movement and arousals. However, individuals may not be consciously aware of these arousals. We examined the baseline concordance of diaries, actigraphy, and PSG as well as the ability of each assessment method to detect changes in sleep following cognitive behavioral therapy for insomnia (CBT-I). Methods: Adults with insomnia and fibromyalgia (n = 113) were randomized to CBT-I, CBT for pain, or waitlist control. At baseline and posttreatment, participants completed one night of PSG and two weeks of diaries/actigraphy. Results: At baseline, objective measures estimated lower SOL, higher TST, and higher SE than diaries (ps < 0.05). Compared to PSG, actigraphic estimates were higher for SOL and lower for WASO (ps < 0.05). Repeated measures ANOVAs were conducted for the CBT-I group (n = 15), and significant method by time interactions indicated that the assessment methods differed in their sensitivity to detect treatment-related changes. PSG values did not change significantly for any sleep parameters. However, diaries showed improvements in SOL, WASO, and SE, and actigraphy also detected the WASO and SE improvements (ps < 0.05). Conclusions: Actigraphy was generally more concordant with PSG than with diaries, which are the recommended assessment for diagnosing insomnia. However, actigraphy showed greater sensitivity to treatment-related changes than PSG; PSG failed to detect any improvements, but actigraphy demonstrated changes in WASO and SE, which were also found with diaries. In comorbid insomnia/fibromyalgia, actigraphy may therefore have utility in measuring treatment outcomes.
AB - Study Objectives: In insomnia, actigraphy tends to underestimate wake time compared to diaries and PSG. When chronic pain co-occurs with insomnia, sleep may be more fragmented, including more movement and arousals. However, individuals may not be consciously aware of these arousals. We examined the baseline concordance of diaries, actigraphy, and PSG as well as the ability of each assessment method to detect changes in sleep following cognitive behavioral therapy for insomnia (CBT-I). Methods: Adults with insomnia and fibromyalgia (n = 113) were randomized to CBT-I, CBT for pain, or waitlist control. At baseline and posttreatment, participants completed one night of PSG and two weeks of diaries/actigraphy. Results: At baseline, objective measures estimated lower SOL, higher TST, and higher SE than diaries (ps < 0.05). Compared to PSG, actigraphic estimates were higher for SOL and lower for WASO (ps < 0.05). Repeated measures ANOVAs were conducted for the CBT-I group (n = 15), and significant method by time interactions indicated that the assessment methods differed in their sensitivity to detect treatment-related changes. PSG values did not change significantly for any sleep parameters. However, diaries showed improvements in SOL, WASO, and SE, and actigraphy also detected the WASO and SE improvements (ps < 0.05). Conclusions: Actigraphy was generally more concordant with PSG than with diaries, which are the recommended assessment for diagnosing insomnia. However, actigraphy showed greater sensitivity to treatment-related changes than PSG; PSG failed to detect any improvements, but actigraphy demonstrated changes in WASO and SE, which were also found with diaries. In comorbid insomnia/fibromyalgia, actigraphy may therefore have utility in measuring treatment outcomes.
KW - Actigraphy
KW - Assessment
KW - Chronic pain
KW - Clinical trial
KW - Cognitive behavioral therapy
KW - Fibromyalgia
KW - Insomnia
KW - Polysomnography
UR - http://www.scopus.com/inward/record.url?scp=84959291172&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959291172&partnerID=8YFLogxK
U2 - 10.5664/jcsm.5488
DO - 10.5664/jcsm.5488
M3 - Article
C2 - 26414976
AN - SCOPUS:84959291172
SN - 1550-9389
VL - 12
SP - 215
EP - 223
JO - Journal of Clinical Sleep Medicine
JF - Journal of Clinical Sleep Medicine
IS - 2
ER -